Efficacy of nirsevimab against respiratory syncytial virus lower respiratory tract infections in preterm and term infants, and pharmacokinetic extrapolation to infants with congenital heart disease and chronic lung disease: a pooled analysis of randomised controlled trials

Publication | Open Access

DOI Full Paper Access

283

Citations

References

2023

Year

Eric A. F. Simões, Shabir A. Madhi, William J. Muller, Victoria Atanasova, Miroslava Bosheva, Fernando Cabañas, Manuel Baca Cots, Joseph B. Domachowske, María Luz García‐García, Ineta Grantiņa,

The Lancet Child & Adolescent Health

AsthmaRespiratory Syncytial VirusRespiratory DiseasesPediatricsRespiratory InfectionPediatric Lung DiseaseAntiviral TherapyInfectious Respiratory DiseaseAntiviral DrugMedicineCongenital Heart DiseaseRespiratory Tract Infections